Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium

View source ↗

Summary

A Belgium-based clinical trial recruiting adults with advanced Parkinson's disease to evaluate changes in disease symptoms after subcutaneous foslevodopa/foscar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Foscarbidopa (foscarbidopa)
  • Foslevodopa (foslevodopa)

Snippet

Sponsor: AbbVie | Conditions: Parkinson's Disease | Status: RECRUITING